EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretion

Megan E Capozzi, David Bouslov, Ashot Sargsyan, Michelle Y Chan, Alex Chen, Sarah M Gray, Katrina Viloria, Akshay Bareja, Jonathan D Douros, Sophie L Lewandowski, Jason Cl Tong, Annie Hasib und 12 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci183741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Megan E Capozzi und 23 weiteren Autor:innen. Beteiligte Einrichtung: Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: GTP-Binding Protein alpha Subunits, Gs, Insulin-Secreting Cells, Insulin Secretion, Insulin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, BLRD VA, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incretin peptides glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors coordinate β cell secretion that is proportional to nutrient intake. This effect permits consistent and restricted glucose excursions across a range of carbohydrate intake. The canonical signaling downstream of ligand-activated incretin receptors involves coupling to Gαs protein and generation of intracellular cAMP. However, recent reports have highlighted the importance of additional signaling nodes engaged by incretin receptors, including other G proteins and β-arrestin proteins. Here, the importance of Gαs signaling was tested in mice with conditional, postdevelopmental β cell deletion of Gnas (encoding Gαs) under physiological and pharmacological conditions. Deletion of Gαs/cAMP signaling induced immediate and profound hyperglycemia that responded minimally to incretin receptor agonists, a sulfonylurea, or bethanechol. While islet area and insulin content were not affected in Gnas βcell–/– , perifusion of isolated islets demonstrated impaired responses to glucose, incretins, acetylcholine, and IBMX In the absence of Gαs, incretin-stimulated insulin secretion was impaired but not absent, with some contribution from Gαq signaling. Collectively, these findings validate a central role for cAMP in mediating incretin signaling, but also demonstrate broad impairment of insulin secretion in the absence of Gαs that causes both fasting hyperglycemia and glucose intolerance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GTP-Binding Protein alpha Subunits, GsInsulin-Secreting CellsInsulin SecretionInsulinSignal TransductionAnimalsMiceMice, KnockoutChromograninsCyclic AMPMaleHyperglycemia

Stichwörter der Autor:innen

DiabetesEndocrinologyG proteinsInsulinMetabolism

Substanzen

GTP-Binding Protein alpha Subunits, GsGnas protein, mouseInsulinChromograninsCyclic AMP

Autor:innen und Institutionen

  • Duke Molecular Physiology Institute, Duke University, Durham, North Carolina, USA.
  • Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington, USA.
  • Department of Neurobiology, Physiology and Behavior, University of California, Davis, Davis, California, USA.
  • Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, Churchill Hospital, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Department of Metabolism and Systems Science, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.
  • Indiana Biosciences Research Institute, Indianapolis, Indiana, USA.

Förderung

  • NIDDK NIH HHS
  • BLRD VA
  • National Institutes of Health

Zitieren

APA

Capozzi, M. E., Bouslov, D., Sargsyan, A., Chan, M. Y., Chen, A., Gray, S. M., Viloria, K., Bareja, A., Douros, J. D., Lewandowski, S. L., Tong, J. C., Hasib, A., Cuozzo, F., Ross, E. C., Foster, M. W., Weinstein, L. S., Hussain, M. A., Merrins, M. J., Willard, F. S., …, & Campbell, J. E. (2025). β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretion. Journal of Clinical Investigation. https://doi.org/10.1172/jci183741

Vancouver

Capozzi ME, Bouslov D, Sargsyan A, Chan MY, Chen A, Gray SM, et al. β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretion. Journal of Clinical Investigation. 2025. doi:10.1172/jci183741

BibTeX
@article{Capozzi2025,
  author = {Capozzi, Megan E and Bouslov, David and Sargsyan, Ashot and Chan, Michelle Y and Chen, Alex and Gray, Sarah M and Viloria, Katrina and Bareja, Akshay and Douros, Jonathan D and Lewandowski, Sophie L and Tong, Jason Cl and Hasib, Annie and Cuozzo, Federica and Ross, Elizabeth C and Foster, Matthew W and Weinstein, Lee S and Hussain, Mehboob A and Merrins, Matthew J and Willard, Francis S and Huising, Mark O and Sloop, Kyle W and Hodson, David J and D'Alessio, David A and Campbell, Jonathan E},
  title = {β Cell Gαs signaling is critical for physiological and pharmacological enhancement of insulin secretion},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci183741}
}
Kostenlos starten →